We are live on ! Find out more
MLA

MB, Levis & Associates Portfolio holdings

AUM $271M
1-Year Est. Return 15.56%
This Fund
S&P 500
This Quarter Est. Return
+4.83%
1 Year Est. Return
+15.56%
3 Year Est. Return
+39.99%
5 Year Est. Return
10 Year Est. Return
AUM
$228M
AUM Growth
+$12.2M
Cap. Flow
+$3.41M
Cap. Flow %
1.5%
Top 10 Hldgs %
63.73%
Holding
286
New
3
Increased
89
Reduced
21
Closed
20

Sector Composition

Rank Sector Weight
1 Technology 7.83%
2 Industrials 4.33%
3 Healthcare 3.93%
4 Financials 3.43%
5 Consumer Staples 2.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VV icon
1
Vanguard Morningstar Large-Cap ETF
VV
$52.4B
$18.3M 8.06%
64,299
+2,215
+4% +$584K
VEU icon
2
Vanguard FTSE All-World ex-US ETF
VEU
$66.6B
$17.5M 7.69%
260,575
+2,306
+0.9% +$146K
DHS icon
3
WisdomTree US High Dividend Fund
DHS
$1.56B
$15.3M 6.74%
159,831
+435
+0.3% +$40.8K
VTEB icon
4
Vanguard Tax-Exempt Bond Index Fund
VTEB
$45.1B
$15M 6.61%
306,753
+6,009
+2% +$294K
DGRW icon
5
WisdomTree Trust WisdomTree US Quality Dividend Growth Fund
DGRW
$16.7B
$14.1M 6.21%
168,850
+694
+0.4% +$55.1K
IBDW icon
6
iShares iBonds Dec 2031 Term Corporate ETF
IBDW
$2.49B
$13.4M 5.9%
638,727
+10,028
+2% +$207K
IBDV icon
7
iShares iBonds Dec 2030 Term Corporate ETF
IBDV
$3.26B
$13.3M 5.83%
603,760
+9,890
+2% +$214K
IBDZ
8
iShares iBonds Dec 2034 Term Corporate ETF
IBDZ
$866M
$13M 5.7%
496,549
+8,145
+2% +$208K
IBDX icon
9
iShares iBonds Dec 2032 Term Corporate ETF
IBDX
$1.7B
$12.7M 5.59%
503,035
+11,889
+2% +$295K
IBDY icon
10
iShares iBonds Dec 2033 Term Corporate ETF
IBDY
$1.09B
$12.3M 5.4%
474,707
+8,057
+2% +$204K
QGRO icon
11
American Century US Quality Growth ETF
QGRO
$1.97B
$8.99M 3.95%
82,416
+3,381
+4% +$338K
MSFT icon
12
Microsoft
MSFT
$3.45T
$5.58M 2.45%
11,211
-6
-0.1% -$2.61K
JPM icon
13
JPMorgan Chase
JPM
$935B
$4.13M 1.81%
14,240
-165
-1% -$42.1K
AAPL icon
14
Apple
AAPL
$4.54T
$4.08M 1.79%
19,909
-82
-0.4% -$16.6K
CAT icon
15
Caterpillar
CAT
$375B
$3M 1.32%
7,721
-3
-0% -$1K
ADP icon
16
Automatic Data Processing
ADP
$106B
$2.71M 1.19%
8,798
+3
+0% +$921
LOW icon
17
Lowe's Companies
LOW
$117B
$2.4M 1.06%
10,827
+4
+0% +$893
ABT icon
18
Abbott
ABT
$183B
$2.35M 1.03%
17,270
+17
+0.1% +$2.24K
EMR icon
19
Emerson Electric
EMR
$83.9B
$1.98M 0.87%
14,860
-56
-0.4% -$6.42K
QCOM icon
20
Qualcomm
QCOM
$155B
$1.95M 0.86%
12,266
+24
+0.2% +$3.53K
IWN icon
21
iShares Russell 2000 Value ETF
IWN
$14.3B
$1.85M 0.81%
11,715
-141
-1% -$21K
PG icon
22
Procter & Gamble
PG
$336B
$1.84M 0.81%
11,537
-46
-0.4% -$7.51K
WMT icon
23
Walmart Inc
WMT
$885B
$1.81M 0.79%
18,490
+347
+2% +$33.1K
JNJ icon
24
Johnson & Johnson
JNJ
$618B
$1.78M 0.78%
11,676
+135
+1% +$20.8K
RTX icon
25
RTX Corp
RTX
$290B
$1.72M 0.76%
11,813
-48
-0.4% -$6.4K

Similar funds

MB, Levis & Associates's Q2 2025 Portfolio in Review

As of Q2 2025, MB, Levis & Associates held 286 positions worth $228M, up 5.7% from $215M the previous quarter. Its ten largest holdings account for 64% of the portfolio.

MB, Levis & Associates's Q2 2025 filing shows 3 new, 89 increased, 21 reduced and 20 closed positions. Its largest new stake was Fidelity High Dividend ETF: 541 shares worth $28.1K. The largest sale was BlackRock Health Sciences Trust, an estimated $58K.

By sector, the portfolio is most concentrated in Technology at 7.8% of assets, up from 7.4% a quarter earlier, followed by Industrials and Healthcare.

  • MB, Levis & Associates's largest Q2 2025 buy was Fidelity High Dividend ETF: 541 shares worth $28.1K.
  • MB, Levis & Associates added most to Vanguard Morningstar Large-Cap ETF in Q2 2025, an estimated $584K increase.
  • MB, Levis & Associates's biggest Q2 2025 reduction was Vanguard Total Bond Market, cutting an estimated $52.1K.
  • MB, Levis & Associates fully exited BlackRock Health Sciences Trust in Q2 2025, selling an estimated $58K.
  • MB, Levis & Associates's ten largest holdings make up 64% of its $228M portfolio in Q2 2025.
  • MB, Levis & Associates opened 3 new positions and closed 20 in Q2 2025.
  • MB, Levis & Associates's portfolio value rose 5.7% quarter-over-quarter to $228M.

Based on MB, Levis & Associates's 13F filing for Q2 2025, filed 29 Jul 2025.